Susten VT 200 Mg

Price range: 72.00$ through 136.00$

Product Overview Susten VT 200 Mg is a prescription vaginal insert manufactured by Sun Pharmaceutical Industries Ltd. Each strip contains ten (10) soft gelatinous inserts delivering 200 mg of natural progesterone. The product is indicated for the tre

Active Ingredients	Progesterone
Delivery Time	6 To 15 days
Indication	female infertility, Hormone replacement therapy
Manufacturer	Sun Pharmaceutical Industries Ltd
Packaging	10 vaginal insert in 1 strip
Strength	200mg

Estimated Delivery: Sat, Oct 10 – Mon, Oct 12

... people are viewing this right now

Guaranteed Safe Checkout

Pack Size	Price	Quantity
30 Tablet/s	72.00$
60 Tablet/s	102.00$
90 Tablet/s	136.00$

🚚 Worldwide Shipping — Fully Tracked & Insured

United States

Standard tracked delivery

7–14 Business Days

United Kingdom

Standard tracked delivery

5–10 Business Days

Australia

Standard tracked delivery

10–18 Business Days

Rest of World

50+ countries available

10–20 Business Days

All orders are shipped in plain, discreet packaging with no pharmacy or medicine reference outside. Tracking number is sent by email after dispatch. Shipped from Mumbai, India.

Description

Product Overview

Susten VT 200 Mg is a prescription vaginal insert manufactured by Sun Pharmaceutical Industries Ltd. Each strip contains ten (10) soft gelatinous inserts delivering 200 mg of natural progesterone. The product is indicated for the treatment of female infertility and as an adjunct in hormone replacement therapy (HRT) for post‑menopausal women.

What is Susten VT 200 Mg

Susten VT 200 Mg belongs to the class of progestogens that mimic the natural hormone progesterone. Progesterone prepares the endometrium for implantation and maintains early pregnancy. In clinical practice it is used to support the luteal phase in assisted reproductive techniques and to reduce the risk of estrogen‑induced endometrial hyperplasia when combined with estrogen in HRT.

Uses and Benefits

The primary uses of Susten VT 200 Mg include ovulation induction support, embryo implantation assistance, and endometrial protection in combined estrogen‑progesterone regimens. Benefits reported in clinical studies include improved pregnancy rates in IVF cycles, reduced incidence of breakthrough bleeding, and better symptom control during menopause when combined with appropriate estrogen therapy.

Because the medication is delivered vaginally, it bypasses the gastrointestinal tract and provides steady systemic exposure with minimal first‑pass metabolism. This route also reduces the risk of gastrointestinal side effects commonly associated with oral progestins.

How It Works

When administered as a vaginal insert, the gelatinous matrix dissolves and releases 200 mg of progesterone directly into the surrounding tissue. The hormone then diffuses into the uterine lining, where it binds to intracellular progesterone receptors. This binding triggers transcriptional changes that promote secretory transformation of the endometrium, making it receptive to embryo implantation.

The controlled release profile ensures that therapeutic levels are maintained for approximately 24 hours, allowing once‑daily dosing. The local delivery also minimizes systemic exposure, which is advantageous for patients who are sensitive to high dose progestogenic effects.

Dosage Guidelines

Susten VT 200 Mg is supplied as a single‑dose vaginal insert. The usual clinical protocol involves one insert placed in the vagina at bedtime for a prescribed number of days each month, typically ranging from 10 to 12 days depending on the underlying condition and physician judgment. Patients should be instructed to wash their hands before handling the insert and to avoid inserting the medication if the vaginal environment is excessively dry or inflamed.

Dosage adjustments are not based on weight but on the clinical response and any concurrent hormone therapy. It is essential that the prescribing clinician reviews the patient’s complete medication list and medical history before initiating treatment.

Side Effects

Like all pharmaceutical products, Susten VT 200 Mg may cause adverse effects. The most commonly reported side effects include mild irritation of the vaginal mucosa, spotting, and transient breast tenderness. Less frequent but clinically important events include headache, abdominal discomfort, and mood changes.

Most side effects are mild and resolve spontaneously after the first few cycles of use. However, patients should contact their healthcare provider if they experience severe abdominal pain, heavy vaginal bleeding, signs of allergic reaction such as rash or swelling, or any symptoms that persist beyond the expected treatment window.

Warnings and Precautions

Susten VT 200 Mg should not be used in patients with a known or suspected history of thromboembolic disorders, liver disease, or unexplained vaginal bleeding. It is contraindicated in pregnant women unless specifically prescribed as part of a controlled fertility protocol.

Patients with a history of certain cancers, particularly estrogen‑dependent tumors, should discuss the risks with their physician before starting therapy. Regular monitoring of endometrial thickness via ultrasound is recommended when the medication is used in combination with estrogen.

It is advisable to review current medications for potential interactions, especially with corticosteroids, anticonvulsants, or other hormonal agents that may affect metabolism.

Frequently Asked Questions

Question 1: What is the recommended storage condition for Susten VT 200 Mg inserts?

Answer: The inserts should be stored at room temperature, protected from moisture and direct sunlight. Keep the strip sealed until ready for use, and do not refrigerate unless instructed by a healthcare professional.

Question 2: Can Susten VT 200 Mg be used together with estrogen therapy?

Answer: Yes, it is often prescribed in combination with estrogen for hormone replacement therapy or for endometrial protection during IVF cycles. However, the combination should be supervised by a qualified clinician who can tailor the dosing schedule.

Question 3: How long does it take to see results after starting treatment?

Answer: Improvement in menstrual regularity or pregnancy rates may become apparent after one to three treatment cycles, depending on the underlying diagnosis and individual response. Patience and regular follow‑up are essential.

Question 4: Is the vaginal insert reusable?

Answer: No, each insert is intended for single‑use only. Used inserts should be discarded in a safe manner, and a fresh insert should be administered as directed by the prescribing clinician.

Question 5: Where can I find more detailed prescribing information?

Answer: Detailed prescribing information, including full safety data, is available on the official product label and can also be accessed through reputable medical databases such as the National Center for Biotechnology Information or the U.S. Food and Drug Administration website.